Published in Gut on September 01, 1997
Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease: an inherited defect in mucosal defence? Gut (1999) 2.01
Role of mast cells in chronic stress induced colonic epithelial barrier dysfunction in the rat. Gut (2001) 1.46
Augmented increase in tight junction permeability by luminal stimuli in the non-inflamed ileum of Crohn's disease. Gut (2002) 1.41
Intestinal permeability and inflammation in patients on NSAIDs. Gut (1998) 1.12
Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy. World J Gastroenterol (2013) 1.10
Exacerbation of inflammatory bowel diseases associated with the use of nonsteroidal anti-inflammatory drugs: myth or reality? Eur J Clin Pharmacol (2009) 1.05
Epithelia under metabolic stress perceive commensal bacteria as a threat. Am J Pathol (2004) 1.05
Intestinal permeability in the pathogenesis of NSAID-induced enteropathy. J Gastroenterol (2009) 1.02
Rebamipide significantly inhibits indomethacin-induced mitochondrial damage, lipid peroxidation, and apoptosis in gastric epithelial RGM-1 cells. Dig Dis Sci (2005) 1.01
Assessment of drug-induced mitochondrial dysfunction via altered cellular respiration and acidification measured in a 96-well platform. J Bioenerg Biomembr (2012) 0.98
Aspirin induces apoptosis through release of cytochrome c from mitochondria. Neoplasia (2001) 0.97
Multiple NSAID-induced hits injure the small intestine: underlying mechanisms and novel strategies. Toxicol Sci (2012) 0.96
Pharmacologic targeting of bacterial β-glucuronidase alleviates nonsteroidal anti-inflammatory drug-induced enteropathy in mice. J Pharmacol Exp Ther (2012) 0.96
Current perspectives in NSAID-induced gastropathy. Mediators Inflamm (2013) 0.91
Impaired barrier function by dietary fructo-oligosaccharides (FOS) in rats is accompanied by increased colonic mitochondrial gene expression. BMC Genomics (2008) 0.87
Effects of esomeprazole on glutathione levels and mitochondrial oxidative phosphorylation in the gastric mucosa of rats treated with indomethacin. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.85
Bioenergetics of immune cells to assess rheumatic disease activity and efficacy of glucocorticoid treatment. Ann Rheum Dis (2003) 0.84
Effects of dipyrone on inflammatory infiltration and oxidative metabolism in gastric mucosa: comparison with acetaminophen and diclofenac. Dig Dis Sci (2002) 0.83
Mitochondrial dysfunction in inflammatory bowel disease. Front Cell Dev Biol (2015) 0.83
Rebamipide suppresses diclofenac-induced intestinal permeability via mitochondrial protection in mice. World J Gastroenterol (2012) 0.83
Relationship between endogenous colony stimulating factors and apoptosis in human colon cancer cells: role of cyclo-oxygenase inhibitors. Br J Pharmacol (2001) 0.82
Neutrophil migration into indomethacin induced rat small intestinal injury is CD11a/CD18 and CD11b/CD18 co-dependent. Gut (2002) 0.82
Determining small bowel integrity following drug treatment. Br J Clin Pharmacol (2003) 0.82
Mitochondrial disorders in NSAIDs-induced small bowel injury. J Clin Biochem Nutr (2011) 0.82
Etanercept attenuates TNBS-induced experimental colitis: role of TNF-α expression. J Mol Histol (2011) 0.81
cPLA2 is protective against COX inhibitor-induced intestinal damage. Toxicol Sci (2010) 0.81
Effect of COX-2 inhibitor lumiracoxib and the TNF-α antagonist etanercept on TNBS-induced colitis in Wistar rats. J Mol Histol (2012) 0.80
Effect of COX-2 inhibitor after TNBS-induced colitis in Wistar rats. J Mol Histol (2009) 0.80
Nitro-arginine methyl ester, a non-selective inhibitor of nitric oxide synthase reduces ibuprofen-induced gastric mucosal injury in the rat. Dig Dis Sci (2005) 0.80
Copper-indomethacinate associated with zwitterionic phospholipids prevents enteropathy in rats: effect on inducible NO synthase. Dig Dis Sci (1999) 0.80
Orengedokuto and berberine improve indomethacin-induced small intestinal injury via adenosine. J Gastroenterol (2009) 0.80
Protective effect of metronidazole on uncoupling mitochondrial oxidative phosphorylation induced by NSAID: a new mechanism. Gut (2001) 0.80
Hitting the Bull's-Eye in Metastatic Cancers-NSAIDs Elevate ROS in Mitochondria, Inducing Malignant Cell Death. Pharmaceuticals (Basel) (2015) 0.79
Hydrogen sulphide protects against NSAID-enteropathy through modulation of bile and the microbiota. Br J Pharmacol (2014) 0.78
Small-bowel mucosal injuries in low-dose aspirin users with obscure gastrointestinal bleeding. World J Gastroenterol (2014) 0.78
Effects of oral adenosine 5'-triphosphate and adenosine in enteric-coated capsules on indomethacin-induced permeability changes in the human small intestine: a randomized cross-over study. BMC Gastroenterol (2007) 0.78
A protective effect of melatonin on intestinal permeability is induced by diclofenac via regulation of mitochondrial function in mice. Acta Pharmacol Sin (2011) 0.78
NSAID enteropathy and bacteria: a complicated relationship. J Gastroenterol (2015) 0.78
Live probiotic cultures and the gastrointestinal tract: symbiotic preservation of tolerance whilst attenuating pathogenicity. Front Cell Infect Microbiol (2014) 0.77
Interaction of plant cell signaling molecules, salicylic acid and jasmonic acid, with the mitochondria of Helicoverpa armigera. J Bioenerg Biomembr (2012) 0.77
Effects of Supplementation of the Synbiotic Ecologic® 825/FOS P6 on Intestinal Barrier Function in Healthy Humans: A Randomized Controlled Trial. PLoS One (2016) 0.77
The effects of lectins on indomethacin-induced small intestinal ulceration. Int J Exp Pathol (2003) 0.77
Effect of drug release rate on therapeutic outcomes: formulation dependence of gastrointestinal toxicity of diclofenac in the rat. Inflammopharmacology (2004) 0.77
Enantiomers of flurbiprofen can distinguish key pathophysiological steps of NSAID enteropathy in the rat. Gut (1998) 0.76
2, 4-diamino-6- hydroxy pyrimidine inhibits NSAIDs induced nitrosyl-complex EPR signals and ulcer in rat jejunum. BMC Gastroenterol (2002) 0.76
Association between NSAIDs and Clostridium difficile-Associated Diarrhea: A Systematic Review and Meta-Analysis. Can J Gastroenterol Hepatol (2016) 0.76
Small bowel injury in low-dose aspirin users. J Gastroenterol (2014) 0.76
Disturbance of purine nucleotide metabolism: a possible early key event in development of intestinal damage induced by chemotherapy. Dig Dis Sci (2001) 0.75
Low endotoxemia prevents the reduction of gastric blood flow induced by NSAIDs: role of nitric oxide. Br J Pharmacol (2003) 0.75
Indomethacin injury to the rat small intestine is dependent upon biliary secretion and is associated with overgrowth of enterococci. Physiol Rep (2016) 0.75
Low direct cytotoxicity of nabumetone on gastric mucosal cells. Dig Dis Sci (2005) 0.75
Ibuprofen and chronic pyloric stricture. J Pediatr Gastroenterol Nutr (2010) 0.75
Emu oil offers protection in Crohn's disease model in rats. BMC Complement Altern Med (2016) 0.75
Low direct cytotoxicity and cytoprotective effects of nitric oxide releasing indomethacin. Dig Dis Sci (2005) 0.75
Carprofen-induced oxidative stress in mitochondria of the colonic mucosa of the dog. Can J Vet Res (2014) 0.75
Human Intestinal Barrier Function in Health and Disease. Clin Transl Gastroenterol (2016) 0.75
The presence of 3-hydroxy oxylipins in pathogenic microbes. Prostaglandins Other Lipid Mediat (2011) 0.75
A Review of Anti-Inflammatory Drug-Induced Gastrointestinal Injury: Focus on Prevention of Small Intestinal Injury. Pharmaceuticals (Basel) (2010) 0.75
The role of food for the formation and prevention of gastrointestinal lesions induced by aspirin in cats. Dig Dis Sci (2013) 0.75
Nitric oxide: potential role for reducing gastro-enteropathy. Inflammopharmacology (2003) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
The respiratory chain and oxidative phosphorylation. Adv Enzymol Relat Subj Biochem (1956) 20.40
Intracellular calcium homeostasis. Annu Rev Biochem (1987) 7.68
Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology (1993) 4.93
Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell (1995) 4.17
Nonsteroidal antiinflammatory drugs--differences and similarities. N Engl J Med (1991) 3.05
Indomethacin-induced intestinal lesions in the rat. Toxicol Appl Pharmacol (1970) 2.61
Non-steroidal anti-inflammatory drugs (NSAIDs) associate with zwitterionic phospholipids: insight into the mechanism and reversal of NSAID-induced gastrointestinal injury. Nat Med (1995) 2.15
Small intestinal ulcers and intestinal flora in rats given indomethacin. Am J Pathol (1969) 2.13
Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut (1986) 2.10
Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat. Gastroenterology (1994) 1.76
Mechanisms underlying gastric mucosal damage induced by indomethacin and bile-salts, and the actions of prostaglandins. Br J Pharmacol (1977) 1.68
The biochemical basis of non-steroidal anti-inflammatory drug-induced damage to the gastrointestinal tract: a review and a hypothesis. Scand J Gastroenterol (1995) 1.57
Aspirin-induced ultrastructural changes in human gastric mucosa: correlation with potential difference. Ann Intern Med (1976) 1.49
Misoprostol reduces indomethacin-induced changes in human small intestinal permeability. Dig Dis Sci (1989) 1.46
NSAIDs, Cox-2 inhibitors, and the gut. Lancet (1995) 1.41
Investigation of tissue organelles by a combination of analytical subcellular fractionation and enzymic microanalysis: a new approach to pathology. J Clin Pathol (1981) 1.39
A possible basis for the anti-inflammatory activity of salicylates and other non-hormonal anti-rheumatic drugs. Nature (1958) 1.36
Relationship of the enterohepatic cycle to ulcerogenesis in the rat small bowel with flufenamic acid. Gastroenterology (1970) 1.18
Prostaglandin and cimetidine inhibit the formation of ulcers produced by parenteral salicylates. Gastroenterology (1978) 1.11
Aspirin can inhibit gastric mucosal cyclo-oxygenase without causing lesions in rat. Gastroenterology (1983) 1.08
Analytical subcellular fractionation of jejunal biopsy specimens: enzyme activities, organelle pathology and response to corticosteroids in patients with non-responsive coeliac disease. Clin Sci Mol Med (1978) 1.06
BIOCHEMICAL PROPERTIES OF ANTI-INFLAMMATORY DRUGS--III. UNCOUPLING OF OXIDATIVE PHOSPHORYLATION IN A CONNECTIVE TISSUE (CARTILAGE) AND LIVER MITOCHONDRIA BY SALICYLATE ANALOGUES: RELATIONSHIP OF STRUCTURE TO ACTIVITY. Biochem Pharmacol (1964) 1.06
Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man. Gut (1991) 1.06
Controversies in the detection and management of nonsteroidal antiinflammatory drug-induced side effects of the upper gastrointestinal tract. Arthritis Rheum (1989) 1.04
Ultrastructural observations on the pathogenesis of aspirin-induced gastric erosions. Br J Exp Pathol (1980) 1.03
Early histological features of small intestinal injury induced by indomethacin. Aliment Pharmacol Ther (1993) 1.00
Abolition by omeprazole of aspirin induced gastric mucosal injury in man. Gut (1990) 0.98
Gastric mucosal lesions produced by intravenous infusion of aspirin in cats. Gastroenterology (1976) 0.98
Effect of acetylsalicylic acid on gastric mucosa. II. Mucosal ATP and phosphocreatine content, and salicylate effects on mitochondrial metabolism. Gastroenterology (1977) 0.97
Effects of anionic surfactants on hamster small intestinal membrane structure and function: relationship to surface activity. Gastroenterology (1977) 0.96
The 1994 Merck Frosst Award. Mechanisms of nonsteroidal anti-inflammatory drug (NSAID) induced gastrointestinal damage--potential for development of gastrointestinal tract safe NSAIDs. Can J Physiol Pharmacol (1994) 0.94
Chemical hypoxia increases junctional permeability and activates electrogenic ion transport in human intestinal epithelial monolayers. Surgery (1994) 0.94
Effects of nonsteroidal, antiinflammatory drugs on gastrointestinal injury and prostanoid generation in healthy volunteers. Dig Dis Sci (1988) 0.93
Acute effect of systemic aspirin on gastric mucosa in man. Dig Dis Sci (1980) 0.89
Mechanisms of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs. Scand J Gastroenterol Suppl (1989) 0.88
Antiinflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6-methoxy-2-naphthylacetic acid (6MNA). Comparative studies with indomethacin. Dig Dis Sci (1992) 0.87
Anti-inflammatory/anti-pyretic salicylic acid esters with low gastric ulcerogenic activity. Agents Actions (1980) 0.87
Parietal cells of the stomach trap salicylates during absorption. Biochem Pharmacol (1977) 0.87
Endogenous gastric mucosal prostaglandins: their role in mucosal integrity. Am J Physiol (1982) 0.86
New understandings of NSAID gastropathy. Scand J Rheumatol Suppl (1989) 0.86
Biochemical gastroprotection from acute ulceration induced by aspirin and related drugs. Biochem Pharmacol (1980) 0.86
Inactivation of rat small intestinal brush-border membrane alkaline phosphatase by oxygen free radicals. Gastroenterology (1993) 0.85
Recent insight into the mechanism of gastrointestinal tract ulceration. Scand J Rheumatol Suppl (1987) 0.85
Laxative-like effects of nonsteroidal anti-inflammatory drugs on intestinal fluid movement and membrane integrity. J Pharmacol Exp Ther (1982) 0.85
Injury-induced inhibition of small intestinal protein and nucleic acid synthesis. Gastroenterology (1990) 0.84
Non-steroidal anti-inflammatory drug-induced gastropathy. Mechanisms and management. Med Toxicol Adverse Drug Exp (1989) 0.83
In vitro effects of nonsteroidal anti-inflammatory drugs on oxidative phosphorylation in rats liver mitochondria. Biochem Pharmacol (1977) 0.83
Oxidative phosphorylation and respiration by rat liver mitochondria from aspirin-treated rats. Biochem Pharmacol (1972) 0.79
Aspirin- and taurocholate-induced metabolic damage in mammalian gastric mucosa in vitro. Am J Physiol (1980) 0.79
Strength-duration curves for repetitive stimulation of medullated nerve. J Physiol (1934) 15.94
Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet (1978) 11.99
Integration of cytogenetic landmarks into the draft sequence of the human genome. Nature (2001) 10.96
The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39
Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images. Cytometry A (2004) 8.65
Growth of factor-dependent hemopoietic precursor cell lines. J Exp Med (1980) 5.80
Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology (1993) 4.93
U2 RNA shares a structural domain with U1, U4, and U5 RNAs. EMBO J (1982) 4.68
A dust-obscured massive maximum-starburst galaxy at a redshift of 6.34. Nature (2013) 4.43
Undescribed toxin in pseudomembranous colitis. Br Med J (1977) 4.31
Pseudomembranous colitis: Presence of clostridial toxin. Lancet (1978) 4.30
Pseudomembranous colitis. J Clin Pathol (1977) 3.93
The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. Rheumatology (Oxford) (2002) 3.87
Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology (2000) 3.49
Campylobacter pyloridis in peptic ulcer disease: microbiology, pathology, and scanning electron microscopy. Gut (1985) 3.48
Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology (1994) 3.44
Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans. Gastroenterology (1987) 3.24
Diaphragm disease: pathology of disease of the small intestine induced by non-steroidal anti-inflammatory drugs. J Clin Pathol (1988) 3.21
Nucleotide sequences of nuclear U1A RNAs from chicken, rat and man. Nucleic Acids Res (1980) 3.13
Epidemiology of experimental enterocecitis due to Clostridium difficile. J Infect Dis (1980) 2.95
Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut (2004) 2.92
Acute diarrhoea: Campylobacter colitis and the role of rectal biopsy. J Clin Pathol (1979) 2.86
Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs. Lancet (1984) 2.83
Heatstroke in well-wrapped infants. Lancet (1979) 2.81
WWOX: a candidate tumor suppressor gene involved in multiple tumor types. Proc Natl Acad Sci U S A (2001) 2.79
NSAIDs, Cox-2 inhibitors, and the gut. Lancet (1995) 2.72
A simple method for assessing intestinal inflammation in Crohn's disease. Gut (2000) 2.69
A persistent defect in intestinal permeability in coeliac disease demonstrated by a 51Cr-labelled EDTA absorption test. Lancet (1983) 2.62
Overlap in the spectrum of non-specific inflammatory bowel disease--'colitis indeterminate'. J Clin Pathol (1978) 2.56
Comparison of two serologically distinct ribonucleic acid bacteriophages. I. Properties of the viral particles. J Bacteriol (1966) 2.52
Primary and secondary structures of chicken, rat and man nuclear U4 RNAs. Homologies with U1 and U5 RNAs. Nucleic Acids Res (1981) 2.51
The conformation of chicken, rat and human U1A RNAs in solution. Nucleic Acids Res (1981) 2.50
Group A beta-hemolytic streptococci resistant to erythromycin and lincomycin. N Engl J Med (1968) 2.44
Inflammatory bowel disease: the surgical pathology of Crohn's disease and ulcerative colitis. Hum Pathol (1975) 2.37
Bilateral human fetal striatal transplantation in Huntington's disease. Neurology (2002) 2.34
The leaky gut of alcoholism: possible route of entry for toxic compounds. Lancet (1984) 2.30
A critical assessment of screening methods for cervical neoplasia. Int J Gynaecol Obstet (2005) 2.27
An effective integrated learning programme in the first year of the medical course. Natl Med J India (2008) 2.24
Absorption of 51chromium-labeled ethylenediaminetetraacetate in inflammatory bowel disease. Gastroenterology (1983) 2.23
Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut (1996) 2.23
Clinicopathological features of nonsteroidal antiinflammatory drug-induced small intestinal strictures. Gastroenterology (1988) 2.20
Methane-oxidizing microorganisms. Microbiol Rev (1981) 2.17
Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial. Ann Intern Med (1996) 2.17
Studies on epithelial cells isolated from guinea pig small intestine. J Cell Biol (1971) 2.17
Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis (2008) 2.12
How should different life expectancies be valued? BMJ (1998) 2.10
Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut (1986) 2.10
Possible manifestation of temporomandibular joint dysfunction on chiropractic cervical X-ray studies. J Manipulative Physiol Ther (1999) 2.09
Molecular, immunological, and biological characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile. Infect Immun (1992) 2.07
[Metabolic alkalosis despite hyperlactatemia and hypercapnia. Interpretation and therapy with help of the Stewart concept]. Anaesthesist (2008) 2.05
BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatology (Oxford) (2007) 2.02
Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force. Ann Rheum Dis (2007) 2.01
Absence of dyspeptic symptoms as a test of Helicobacter pylori eradication. BMJ (1996) 1.98
The nuclear 5S RNAs from chicken, rat and man. U5 RNAs are encoded by multiple genes. Nucleic Acids Res (1981) 1.96
Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther (2002) 1.94
Endomysial antibody: is it the best screening test for coeliac disease? Gut (1992) 1.93
Food intolerance and Crohn's disease. Gut (1993) 1.84
Clinical and laboratory profile of AIDS in India. J Acquir Immune Defic Syndr (1992) 1.83
Isolation and characterisation of a bipotential haematopoietic cell line. Nature (1979) 1.80
The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome. J Clin Endocrinol Metab (1996) 1.80
Percutaneous endoscopic gastrostomy. BMJ (1992) 1.80
Immunologic responses in malnourished children. Am J Clin Nutr (1975) 1.78
An evaluation of small nuclear RNA in hnRNP. FEBS Lett (1979) 1.78
Lactulose, 51Cr-labelled ethylenediaminetetra-acetate, L-rhamnose and polyethyleneglycol 400 [corrected] as probe markers for assessment in vivo of human intestinal permeability. Clin Sci (Lond) (1986) 1.78
Granulomatous ulcerative colitis: a re-appraisal of the mucosal granuloma in the distinction of Crohn's disease from ulcerative colitis. Histopathology (2002) 1.76
Experimental analysis of the origin of the wing musculature in avian embryos. Anat Embryol (Berl) (1977) 1.73
Early Permian bipedal reptile. Science (2000) 1.73
International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford) (2003) 1.71
Complexity of the structure of particles containing heterogeneous nuclear RNA as demonstrated by ribonuclease treatment. Eur J Biochem (1977) 1.69
Two functional states of the CD11b A-domain: correlations with key features of two Mn2+-complexed crystal structures. J Cell Biol (1998) 1.67
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Cell death, chromosome damage and mitotic delay in normal human, ataxia telangiectasia and retinoblastoma fibroblasts after x-irradiation. Int J Radiat Biol Relat Stud Phys Chem Med (1981) 1.66
High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut (1999) 1.63
Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut (2004) 1.63
Salmonella ealing infections associated with consumption of infant dried milk. Lancet (1987) 1.62
The effect of elemental diet on intestinal permeability and inflammation in Crohn's disease. Gastroenterology (1991) 1.61
Increased chromosomal radiosensitivity in breast cancer patients: a comparison of two assays. Int J Radiat Biol (1999) 1.61
The economic and quality-of-life benefits of Helicobacter pylori eradication in chronic duodenal ulcer disease--a community-based study. Postgrad Med J (1995) 1.59
The biochemical basis of non-steroidal anti-inflammatory drug-induced damage to the gastrointestinal tract: a review and a hypothesis. Scand J Gastroenterol (1995) 1.57
Reduced bone density in patients with inflammatory bowel disease. Gut (1997) 1.56
Non-invasive investigation of inflammatory bowel disease. World J Gastroenterol (2001) 1.54
Intestinal absorptive capacity, intestinal permeability and jejunal histology in HIV and their relation to diarrhoea. Gut (1995) 1.54
Pre-pouch ileitis: a disease of the ileum in ulcerative colitis after restorative proctocolectomy. Colorectal Dis (2006) 1.52
Sexual mimicry regulates the attractiveness of mated Drosophila melanogaster females. Proc Natl Acad Sci U S A (1986) 1.52
Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer? Am J Hum Genet (1999) 1.51
Tumour induction by methyl-nitroso-urea following preconceptional paternal contamination with plutonium-239. Br J Cancer (1998) 1.50
The British Society of Gastroenterology early gastric cancer/dysplasia survey: an interim report. Gut (1990) 1.49
Preliminary evaluation of "duodenitis" by endoscopy and biopsy. Br Med J (1973) 1.48
Metronidazole reduces intestinal inflammation and blood loss in non-steroidal anti-inflammatory drug induced enteropathy. Gut (1992) 1.47
Biological, pathological and physical characterization of a possible variant of a murine sarcoma virus (Moloney). Int J Cancer (1968) 1.47